Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life ...

‘Bewildering’ arguments heard in major UK patent hearing at UK Supreme Court | Cluedo analogy and famous tracks used by UKIPO ...

Partner spent time as senior counsel at Forrest Weldon | New hire will be instrumental in developing next generation of IP ...

22 July 2024 Court determined that artificial neural networks cannot be patented as they are considered computer programs | ...

Important cases on discretionary denials, prosecution latches, and trade secrets have been heard at the appellate court over June and July, explain Nathan Mammen and Cole Tipton of Snell & Wilmer.